Binding of 3H-metronidazole in olfactory, respiratory and alimentary epithelia in rats

Pharmacology and Toxicology

Volumn 81, Issue 2, 1997, Pages 65-73

  Larsson, Pia ^a   Cybulski, Wojciech ^b   Tjälve, Hans ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; METRONIDAZOLE; CYTOCHROME P450; ENZYME INHIBITOR; GLUTATHIONE; METYRAPONE; NITROGEN; PROTEIN; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG METABOLISM; ESOPHAGUS; FEMALE; FORESTOMACH; GINGIVA; INTESTINE EPITHELIUM; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OLFACTORY EPITHELIUM; PALATE; PHARYNX; PRIORITY JOURNAL; RAT; RESPIRATORY EPITHELIUM; TONGUE; WHOLE BODY AUTORADIOGRAPHY; ANIMAL; AUTORADIOGRAPHY; BIOTRANSFORMATION; DIGESTIVE SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM; METABOLISM; RESPIRATORY SYSTEM; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALIA;

ANIMALS; AUTORADIOGRAPHY; BIOTRANSFORMATION; CYTOCHROME P-450 ENZYME SYSTEM; DIGESTIVE SYSTEM; ENZYME INHIBITORS; EPITHELIUM; FEMALE; GLUTATHIONE; METRONIDAZOLE; METYRAPONE; NITROGEN; OLFACTORY MUCOSA; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY SYSTEM; TISSUE DISTRIBUTION; TRITIUM;

EID: 0030612785     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb00033.x     Document Type: Article

References (36)

1. Baker, M.T. & R.A. Van Dyke: Metabolism dependent binding of the chlorinated insecticide DDT and its metabolite DDD to microsomal proteins and lipids. Biochem. Pharmacol. 1984, 33, 255-260.
2. Baron, J., J.P. Burke, F.P. Guengerich, W.B. Jakoby & J.M. Voigt: Sites for xenobiotic activation and detoxication within the respiratory tract: Implications for chemically induced toxicity. Toxicol Appl. Pharmacol. 1988, 93, 493-505.
3. Chrystal, E.J.T., R.L. Koch & P. Goldman: Metabolites from the reduction of metronidazole by xanthine oxidase. Mol. Pharmacol. 1980, 18, 105-111.
4. Cobb, L.M., F.R.C. Path & J. Nolan: Autoradiographic study of tritium-labelled misonidazole in the mouse. Int. J. Radiat. Oncol. Biol. Phys. 1989, 16, 953-956.
5. Cobb, L.M.. T. Hacker & J. Nolan: NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radio-labelled misonidazole. Brit. J. Cancer 1990, 61, 524-529.
6. Cybulski, W., P. Larsson, H. Tjälve, H. Kowlska-Pylka, M. Sylla & S. Semeniuk:Disposition of metronidazole in hens (Gallus gallus) and quails (Coturnix coturnix japonica): pharmacokinetics and whole-body autoradiography. J. Vet. Pharmacol. Therap. 1996, 19, 352-358.
7. Dahl, A.R., & W.M. Hadley. Nasal cavity enzymes involved in xenobiotic metabolism: Effects on the toxicity of inhalants. CRC Crit. Rev. Toxicol. 1991, 21, 345-372.
8. Dobiás, L., M. Cerná, P. Rössner & R. Srám: Genotoxicity and carcinogenicity of metronidazole. Mut. Res. 1994, 317, 177-194.
9. Edwards, D.I.: Reduction of nitroimidazoles in vitro and DNA damage. Biochem. Pharmacol. 1986, 35, 53-58.
10. Elliott, T.S.J. & J.W. Stone: Review article: Metronidazole and the anaerobic gut flora. Aliment. Pharmacol. Therap. 1990, 4, 227-238.
11. Goldman, P., R.L. Koch, T.-C. Yeung, E.J.T. Chrystal, B.B. Beaulieu Jr, M.A. McLafferty & G. Sudlow: Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity. Biochem. Pharmacol. 1986, 35, 43-51.
12. Kedderis, G.L., & G.T. Miwa: The metabolic activation of nitroheterocyclic therapeutic agents. Drug Metab. Rev. 1988, 19, 33-62.
13. Kedderis, G.L., L.S. Argenbright & G.T. Miwa: Covalent interaction of 5-nitroimidazoles with DNA and protein in vitro: Mechanism of reductive activation. Chem. Res. Toxicol. 1989, 2, 146-149.
14. Larsson, B.S.: Interaction between chemicals and melanin. Pigment Cell Res. 1993, 6, 127-133.
15. 1 in the bovine olfactory mucosa. Carcinogenesis 1989, 10, 1113-1118.
16. Larsson, P. & H. Tjälve: Binding of aflatoxin B, metabolites in extrahepatic tissues in fetal and infant mice and in adult mice with depleted glutathione levels. Cancer Res. 1992, 52, 1267-1277.
17. Larsson, P. & H. Tjälve: Extrahepatic bioactivation of aflatoxin B1 in fetal, infant and adult rats. Chem.-Biol. Interact. 1995, 94, 1-19.
18. Larsson, P., L. Busk & H. Tjälve: Hepatic and extrahepatic bioactivation and GSH-conjugation of aflatoxin B1 in sheep. Carcinogenesis 1994, 15, 947-955.
19. Loft, S.: Metronidazole and antipyrine as probes for the study of foreign compound metabolism. Pharmacology & Toxicology. 1990, 66, Suppl. VI, 1-31.
20. Lowry, O.H., N.J. Rosenbrough, A.L. Farr & R.J. Randall: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
21. Martelli, A., A. Allavena, L. Robbiano, F. Mattioli & G. Brambilla: Comparison of the sensitivity of human and rat hepatocytes to the genotoxic effects of metronidazole. Pharmacology & Toxicology. 1990, 66, 329-334.
22. Mustofa, M., S. Suryawati & B. Santoso: Pharmacokinetics of metronidazole in saliva. Int. J. Clin. Pharmacol. Therapy Toxicol. 1991, 29, 474-478.
23. Müller, M.: Reductive activation of nitroimidazoles in anaerobic microorganisms. Biochem. Pharmacol. 1986, 35, 37-41.
24. Reed, C.J.: Drug metabolism in the nasal cavity: Relevance to toxicology. Drug Metab. Rev. 1993, 25, 173-205.
25. Roe, F.J.C.: Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential. Surgery 1983, January, 158-163.
26. Rosenkranz, H.S. & W.T. Speck: Mutagenicity of metronidazole: Activation by mammalian liver microsomes. Biochem. Biophys. Res. Comm. 1975, 66, 520-525.
27. Rustia, M. & P. Shubik: Induction of lung tumors and malignant lymphomas in mice by metronidazole. J. Nat. Cancer Inst. 1972, 48, 721-729.
28. Rustia, M. & P. Shubik: Experimental induction of hepatomas. mammary tumors, and other tumors with metronidazole in non-inbred Sas:MRC(WI)BR rats. J. Nat. Cancer Inst. 1979, 63, 863-868.
29. Schwenk, M.: Mucosal biotransformation. Toxicol. Pathol. 1988, 16, 138-146.
30. Shore, P.A., B.B. Brodie & C.A.M. Hogben: The gastric secretion of drugs: A pH partition hypothesis. J. Pharmacol. Exp. Therap 1957, 119, 361-369.
31. Testa, B. & P. Jenner: Inhibitors of cytochrome P-450s and their mechanism of action. Drug Metab. Rev. 1981, 12, 1-117.
32. Tjälve, H.: The tissue distribution and the tissue specificity of bioactivation of some tobacco-specific and some other N-nitrosamines. CRC Critical Rev. in Toxicol. 1991, 21, 265-294.
33. Tjälve, H., P. Larsson, C. Andersson & L. Busk: Bioactivation of aflatoxin B1 in the bovine olfactory mucosa: DNA binding, mutagenicity and induction of sister chromatid exchanges. Carcinogenesis 1992, 13, 1345-1350.
34. Ullberg, S., B. Larsson & H. Tjälve: Autoradiography. In: Biologic applications of radiotracers. Ed.: H.J. Glenn. CRC Press Inc., Boca Raton, Florida, USA, 1982, pp. 56-108.
35. 2? Biochem. Pharmacol. 1987, 36, 3487-3494.
36. Woodrooffe, A. J. M., M. K. Bayliss & G.R. Park: Hypoxia and drug-metabolizing enzymes .Drug Metab. Rev. 1995, 27, 472-495.